Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans
The Journal of Physiology · 2025
DOI: 10.1113/jp288412 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, 2025. Verfasst von Denis J Wakeham und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital, Dallas, TX, USA. Hauptthemen laut MEDLINE: Vasoconstriction, Neuropeptide Y, Sympathetic Nervous System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Metabolic inhibition of sympathetic vasoconstriction (functional sympatholysis) is essential for adequate perfusion of skeletal muscle during exercise. Neuropeptide Y (NPY) is a neurotransmitter that elicits potent vasoconstriction and is co‐released with noradrenaline during sympathoexcitation. NPY is released from sympathetic nerves during exercise; however, no study has assessed whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans. We tested the hypothesis that post‐junctional NPY‐mediated vasoconstriction would be sensitive to metabolic inhibition during handgrip exercise to a similar degree as α 1 ‐adrenergic vasoconstriction. In 12 healthy adults (seven male, age: 30 ± 7 years, body mass index: 24.9 ± 3 kg/m 2 ) we measured forearm blood flow (Doppler ultrasound), blood pressure (brachial artery catheter) and heart rate, and calculated changes in forearm vascular conductance (FVC) to local intra‐arterial infusions of phenylephrine (PE; α 1 ‐agonist) or NPY (Y1R‐agonist) during: (1) intra‐arterial infusion of sodium nitroprusside (SNP; nitric oxide donor), a non‐metabolic vasodilatory control, and (2) dynamic rhythmic handgrip exercise (EX; 15% maximal voluntary contraction). As expected, the vasoconstrictor response to PE was attenuated during handgrip exercise compared to SNP (ΔFVC: SNP: −44 ± 25% vs . EX: −17 ± 9%; P = 0.002). Similarly, NPY‐mediated vasoconstriction was blunted during handgrip exercise compared to SNP (ΔFVC: SNP: −32 ± 22% vs . EX: −11 ± 7%; P = 0.029). There was no difference in the magnitude of sympatholysis between PE and NPY (PE: 68 ± 18 vs . NPY: 52 ± 34%; P = 0.28). NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans, and the magnitude of sympatholysis is not different from α 1 ‐adrenergic vasoconstriction. image Key points Neuropeptide Y (NPY) is a neurotransmitter that is co‐released from sympathetic nerve terminals and elicits potent vasoconstriction, particularly during periods of sympathoexcitation. NPY is released from sympathetic nerves during exercise, but it is currently unclear whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans (i.e. functional sympatholysis). For the first time we have shown that NPY‐mediated vasoconstriction is sensitive to metabolic inhibition during exercise in healthy adults, and that the magnitude of inhibition is similar to the inhibition observed for α 1 ‐adrenergic mediated vasoconstriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital, Dallas, TX, USA.
- Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Applied Clinical Research, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Applied Physiology and Sport Management, Southern Methodist University, Dallas, TX, USA.
- Department of Kinesiology, The University of Texas at Arlington, Arlington, TX, USA.
ORCID-Profile: Denis J Wakeham, Sarah L Hissen, Paul J Fadel, Benjamin D Levine
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Wakeham, D. J., Hissen, S. L., MacNamara, J. P., Davis, S. L., Fadel, P. J., Levine, B. D., & Hearon, C. M. (2025). Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans. The Journal of Physiology. https://doi.org/10.1113/jp288412
Vancouver
Wakeham DJ, Hissen SL, MacNamara JP, Davis SL, Fadel PJ, Levine BD, et al. Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans. The Journal of Physiology. 2025. doi:10.1113/jp288412
BibTeX
@article{Wakeham2025,
author = {Wakeham, Denis J and Hissen, Sarah L and MacNamara, James P and Davis, Scott L and Fadel, Paul J and Levine, Benjamin D and Hearon, Christopher M},
title = {Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans},
journal = {The Journal of Physiology},
year = {2025},
doi = {10.1113/jp288412}
}
EUVIMED